News

The FDA approved the use of daratumumab and hyaluronidase-fihj (Darzalex Faspro) for patients who are newly diagnosed with ...
Teva Pharmaceuticals and Alvotech have announced that the US Food and Drug Administration (FDA) has approved the Selarsdi ...
Humira can cause side effects that range from mild to serious. Examples include injection site reactions, rash, and infections. The active ingredient in Humira is adalimumab. The drug comes as an ...
A toxic metal used in MRI scans may pose greater health risks than previously thought, according to new research. The metal, called gadolinium, is used in contrast agents that are injected into a ...
“‘Safe injections sites,’ ‘harm reduction sites,’ or however they are branded by advocates, are categorically illegal and do nothing to help people overcome their addictions. To the ...
Vyvgart Hytrulo prefilled syringe for self-injection is approved as a 20-to-30-second subcutaneous injection administered by a patient, caregiver, or healthcare professional. The single-dose ...
VYVGART Hytrulo prefilled syringe for self-injection is approved as a 20-to-30-second subcutaneous injection administered by a patient, caregiver, or healthcare professional. Patients can self-inject ...
In December 2024, the Food and Drug Administration (FDA) approved the PD-1 inhibitor nivolumab (Opvido Qvantig) for use as a subcutaneous injection. Read on to learn more about this new approach ...
None of the patients developed a new thromboembolic event or major bleeding episode. This small study demonstrated a high incidence of antibody development possibly associated with the long-term ...
S.B. 57 now heads to Governor Gavin Newsom’s desk. If the bill becomes law, the three cities would be able to maintain safe-injection sites until 2028. Drug users could inject themselves with ...